Christopher Fecarotta
Pediatric Ophthalmology and Strabismus Specialist Phoenix, AZ Doctor of Optometry
NPI 1003072018 CMS profile 903969
9305 W Thomas Rd Ste 460, Phoenix, AZ 85037
General payments
$373,091
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Christopher Fecarotta of Phoenix, AZ is reported in the CMS Open Payments database as having received $373,091 across 29 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Pediatric Ophthalmology and Strabismus Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $93 | 1 | |
| 2023 | General | $220,852 | 14 | |
| 2022 | General | $151,495 | 12 | |
| 2021 | General | $651 | 2 |
Beside peers
- Christopher Fecarotta
- Pediatric Ophthalmology and Strabismus Specialist median
- Middle half of Pediatric Ophthalmology and Strabismus Specialist
- National median
In program year 2025, general payments to Christopher Fecarotta were reported at $93. Among 124 Pediatric Ophthalmology and Strabismus Specialist profiles paid that year, the median was $118 and the middle half received between $36 and $253.
Show as a table
| Year | Christopher Fecarotta | Pediatric Ophthalmology and Strabismus Specialist median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $106 | $24–$276 | $163 |
| 2020 | $0 | $54 | $19–$171 | $114 |
| 2021 | $651 | $118 | $25–$225 | $132 |
| 2022 | $151,495 | $97 | $40–$324 | $149 |
| 2023 | $220,852 | $139 | $78–$441 | $160 |
| 2024 | $0 | $114 | $35–$313 | $164 |
| 2025 | $93 | $118 | $36–$253 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$8,906
Medicare patients
32
Services billed
84
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 53% | |
| Arthritis | 53% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
29 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Ophthalmology and Strabismus Specialist in Arizona
Jamila Hiasat
Pediatric Ophthalmology and Strabismus Specialist · Phoenix, AZ
Jonathan Holmes
Pediatric Ophthalmology and Strabismus Specialist · Tucson, AZ
Mireille Jabroun
Pediatric Ophthalmology and Strabismus Specialist · Tucson, AZ
Emily Shortridge
Pediatric Ophthalmology and Strabismus Specialist · Mesa, AZ
James Plotnik
Pediatric Ophthalmology and Strabismus Specialist · Phoenix, AZ
Sarah Elhomosany
Pediatric Ophthalmology and Strabismus Specialist · Tucson, AZ
Related records
Pediatric Ophthalmology and Strabismus Specialist in Arizona
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Ophthalmology and Strabismus Specialist
Everyone recorded under this specialty, nationwide.
Doctors in Arizona
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.